Mepact 4mg (mifamurtide): Potential for filter leakage or malfunction
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Mepact
|
| Active substance |
mifamurtide
|
| Therapeutic area (MeSH) |
Osteosarcoma
|
| DHPC type |
Quality defect
|
| Human ATC code |
L03AX15
|
| Dissemination date |
25/02/2020
|